**9. Possible clinical applications**

SHetA2 is now in Phase-0 clinical trial for ovarian cancer chemoprevention. However, since it inhibits growth of most cancers *in vitro* and *in vivo*, it may potentially be used for the prevention and treatment of other cancers which are listed in **Table 6**.


**Table 6.** Possible anti-cancer clinical applications of SHetA2 and documented results from different studies.
